SK bioscience Claims Final Victory in mRNA Patent Dispute Against Moderna
South Korea’s SK bioscience, the biopharmaceutical subsidiary of SK Group, announced on Wednesday that it has secured a decisive win in a patent dispute against U.S.-based biotechnology company Moderna, known globally for its development of mRNA COVID-19 vaccines. The legal challenge, initiated in 2023, contested Moderna’s South Korean patent concerning the use and modification of […]